Case Studies & Whitepapers2024-10-28
Co-processing Series: 3. Adsorption
News
More
Case Studies & Whitepapers2025-02-10
Efficacy and Safety - Guidelines for Clinical In-use Stability Studies of ADCs
Antibody-drug conjugates (ADCs) consist of three parts: antibody, linker, and payload. This special combination enables ADCs to selectively target tumor cells and release cytotoxic drugs, but they face many stability challenges during manufacture, storage, and clinical use. In this paper, the drug product development team at Porton (hereinafter referred to as "we") discusses the necessary clinical in-use stability studies for ADCs.

Case Studies & Whitepapers2025-01-06
Molecular Modeling and Data Science for De-risking and Cost- saving of Pharmaceutical Development
Molecular Modeling and Data Science for De-risking and Cost- saving of Pharmaceutical Development